CNE100002102
CNE100002102
WONDFO BIOTECH
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.84B EUR | 7.77B EUR | 8.58B EUR |
Enterprise Value | 5.99B EUR | 8.09B EUR | 8.82B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | 111.73x |
Forward P/E | 14.56x | -- | -- |
Price to Sales | 4.17x | 4.13x | 3.86x |
Price to Book | 1.46x | 1.43x | 1.56x |
EV/Revenue | 3.19x | 4.3x | 3.97x |
EV/EBITDA | 228.37x | -- | 85.76x |
Price to FCF (P/FCF) | 16.24x | 11.15x | 26.86x |
EV/FCF | 12.4x | 11.6x | 27.6x |
FCF Yield | 6.16% | 8.97% | 3.72% |